Compare, Analyse IPCA Labs with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

IPCA LABS vs ADCOCK INGRAM (S. Africa) - Comparison Results

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 IPCA LABS   ADCOCK INGRAM
EQUITY SHARE DATA
    IPCA LABS
Mar-21
ADCOCK INGRAM
Jun-14
IPCA LABS/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs2,456359-   
Low Rs1,371259-   
Sales per share (Unadj.) Rs423.3106.8-  
Earnings per share (Unadj.) Rs90.6-26.9-  
Cash flow per share (Unadj.) Rs107.1-22.3-  
Dividends per share (Unadj.) Rs4.000-  
Avg Dividend yield %0.20-  
Book value per share (Unadj.) Rs370.683.8-  
Shares outstanding (eoy) m126.85168.78-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x4.52.9 156.2%   
Avg P/E ratio x21.1-11.5 -184.0%  
P/CF ratio (eoy) x17.9-13.9 -129.0%  
Price / Book Value ratio x5.23.7 140.0%  
Dividend payout %4.40-   
Avg Mkt Cap Rs m242,72852,133 465.6%   
No. of employees `000NA4.3 0.0%   
Total wages/salary Rs m10,1363,272 309.8%   
Avg. sales/employee Rs Th04,197.1-  
Avg. wages/employee Rs Th0762.2-  
Avg. net profit/employee Rs Th0-1,057.6-  
INCOME DATA
Net Sales Rs m53,69918,018 298.0%  
Other income Rs m1,292126 1,023.9%   
Total revenues Rs m54,99118,144 303.1%   
Gross profit Rs m14,812-3,122 -474.4%  
Depreciation Rs m2,092778 269.0%   
Interest Rs m123488 25.1%   
Profit before tax Rs m13,890-4,262 -325.9%   
Minority Interest Rs m0-12 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,401266 901.7%   
Profit after tax Rs m11,488-4,540 -253.0%  
Gross profit margin %27.6-17.3 -159.2%  
Effective tax rate %17.3-6.2 -276.7%   
Net profit margin %21.4-25.2 -84.9%  
BALANCE SHEET DATA
Current assets Rs m34,37013,197 260.4%   
Current liabilities Rs m11,3317,425 152.6%   
Net working cap to sales %42.932.0 133.9%  
Current ratio x3.01.8 170.7%  
Inventory Days Days49111 43.9%  
Debtors Days Days6124 4.5%  
Net fixed assets Rs m26,2957,692 341.8%   
Share capital Rs m25484 303.3%   
"Free" reserves Rs m46,7630-   
Net worth Rs m47,01714,142 332.5%   
Long term debt Rs m3654,970 7.4%   
Total assets Rs m60,66426,716 227.1%  
Interest coverage x114.2-7.7 -1,476.9%   
Debt to equity ratio x00.4 2.2%  
Sales to assets ratio x0.90.7 131.2%   
Return on assets %19.1-15.2 -126.2%  
Return on equity %24.4-32.1 -76.1%  
Return on capital %29.6-19.8 -149.3%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m19,2230-   
CASH FLOW
From Operations Rs m10,9011,538 708.8%  
From Investments Rs m-5,207-472 1,102.6%  
From Financial Activity Rs m-3,0584,510 -67.8%  
Net Cashflow Rs m2,6365,576 47.3%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.95 Rs / ZAR

Compare IPCA LABS With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare IPCA LABS With: OMKAR PHARMACHEM  JUBILANT PHARMOVA   FERMENTA BIOTECH  MANGALAM DRUGS  SAKAR HEALTHCARE   

Yellow Ad

Advertisement

How to Find One Stock with Crorepati Potential?

There are three critical characteristics that differentiate a common stock from a potential 'crorepati' stock.

And we are going to reveal them during our 'One Stock Crorepati' MEGA summit on 30th June.

If you are interested in finding a potential 'crorepati' stock, don't miss this.

At this MEGA Summit we will reveal details of what we call a 'crorepati' stock...

You just cannot afford to miss this summit for anything.

Learn more



Today's Market

SGX Nifty Down 158 Points, Tata Motors' Price Hike, Ruchi Soya Becomes Patanjali Foods, and Top Buzzing Stocks Today(Pre-Open)

On Tuesday, Indian share markets witnessed a volatile trading session as crude oil prices rebounded following last week's rout.

Related Views On News

5 Takeaways from Sun Pharma's Q4 Results (Views On News)

May 30, 2022

It came as a surprise to everyone when Sun Pharma reported a consolidated net loss in Q4 instead of a profit.

Why Divi's Lab Share Price is Falling (Views On News)

May 24, 2022

Here's why Divi's Lab's stock fell over 10% in two days.

Divi's Lab Net Profit Rises 78%. Company Declares 1,500% Dividend (Views On News)

May 23, 2022

For full year, profit figures stood at Rs 29.6 bn as against Rs 19.8 bn for the previous year, reflecting a growth of 49%.

Dr Reddy's Net Profit Falls 76%. Company Declares 600% Dividend (Views On News)

May 19, 2022

During Q4, there were many changes to the products forming part of Dr Reddy's generics and proprietary products segments.

Cipla vs Sun Pharma: Which Pharma Stock is Better? (Views On News)

Apr 13, 2022

The pandemic has opened up new opportunities for the Indian pharmaceutical sector. Which company is set to benefit from it?

More Views on News

Most Popular

4 Sectors to Watch for Future Multibagger Stocks (Views On News)

Jun 17, 2022

With India's economic recovery accelerating, these sectors are likely to give multibagger returns in the future.

Best Monopoly Stocks to Own in 2022 Views On News (Views On News)

Jun 18, 2022

Constant product innovation, latest technology, strong supply chain etc can all help companies enjoy monopoly like fortunes.

Is it Time to Start Buying Stocks Selectively? (Profit Hunter)

Jun 16, 2022

Some sectors have corrected by 50%. Do they merit a look?

The One Smallcap Stock I'll Recommend Now (Profit Hunter)

Jun 21, 2022

This aspect of investing has a very high weightage on your overall returns, but often gets ignored when winning stories are written.

When Will the Stock Market Recover? (Views On News)

Jun 15, 2022

This is how you can tell the market is going to recover.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

IPCA LABS SHARE PRICE


Jun 28, 2022 (Close)

TRACK IPCA LABS

  • Track your investment in IPCA LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

IPCA LABS 8-QTR ANALYSIS

COMPARE IPCA LABS WITH

MARKET STATS